2023
DOI: 10.14218/jerp.2022.00094
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Liposomal Prostaglandin E1 on Coronary Stenosis and Restenosis after Percutaneous Coronary Intervention: A Prospective Clinical Trial

Abstract: Background and objectives:Restenosis is a serious complication after percutaneous coronary intervention (PCI) for patients with coronary heart disease (CHD). This prospective clinical study was designed to investigate the effects of liposomal prostaglandin E1 (lipo-PGE1) on coronary stenosis and restenosis.Methods: Sixty patients diagnosed with CHD and scheduled for PCI surgery in Guangdong Hospital of Traditional Chinese Medicine were enrolled in this study. The patients were divided into either the Control g… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 21 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?